Browse By

Schweiger Dermatology group leaving Midtown for Long Island City

27-01 Queens Plaza North

It’s time to move

Famous dermatology group, Schweiger, decided to leave midtown. The company signed a sublease renting a 21,463 square foot space. They will be relocating their headquarters there, at 27-01 Queens Plaza North. The group is moving from Midtown to Long Island City. Schweiger is known for providing medical, cosmetic and surgical dermatology care for its customers.

After the move, the group will settle in the entire 10th floor of the building. This tower has 13 stories and belongs to Brause Realty. Located between the 27th and 28th Streets, Brause Realty has owned the Plaza North for the last six years.

The move will happen in September. Currently, Schweiger occupies an 8,000 square foot office space located at 156 West 56th Street. This building is between Avenue of the Americas and Seventh Avenue, in Midtown. Nowadays, MetLife occupies the 10th floor of the Plaza North. This company’s space spans 200,000 square feet at the building, which has a total of 710,000 square feet.

A successful transaction

MetLife subleased the 10th floor with the help of a team from Cushman & Wakefield, while a team from Newmark Knight Frank represented Schweiger. The transaction has been very successful, since Schweiger has doubled the space for their headquarters while maintaining similar occupancy costs.

Overall, Schweiger owns 26 different locations. Furthermore, they are spread all over, with bases in NYC, Long Island, Westchester County and New Jersey, just to name a few. According to the company’s website, they provide services for a quarter of a million patients annually. In addition, the new headquarters are strategically placed. They will be very close to most locations and will serve all 26 of them.

“We will be able to efficiently support our providers and patients as our business continues to grow. We look forward to getting to know our new home at Queens Plaza”, Schweiger Chief Executive Officer Dr. Eric Schweiger said in a statement. [Commercial Observer]